doi: 10.1016/j.vaccine.2009.11.051.
Epub 2009 Dec 8.
Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever
Affiliations
- PMID: 20003920
- DOI: 10.1016/j.vaccine.2009.11.051
Item in Clipboard
Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever
Vaccine.
.
Abstract
After a single injection of Typhim Vi (typhoid Vi polysaccharide vaccine), serum antibody concentrations were monitored for 3 years in 37 adults who resided where typhoid fever was not endemic. Anti-Vi antibody concentrations declined progressively during the study, to levels that support the current US recommendation for revaccination every 2 years.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.Pediatr Infect Dis J. 2007 Nov;26(11):1001-5. doi: 10.1097/INF.0b013e31812565bc. Pediatr Infect Dis J. 2007. PMID: 17984806 Clinical Trial.
-
Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.East Afr Med J. 1995 Mar;72(3):162-4. East Afr Med J. 1995. PMID: 7796767 Clinical Trial.
-
Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.J Infect Dis. 2004 Aug 1;190(3):565-70. doi: 10.1086/421469. Epub 2004 Jun 30. J Infect Dis. 2004. PMID: 15243933 Clinical Trial.
-
Population impact of Vi capsular polysaccharide vaccine.Expert Rev Vaccines. 2010 May;9(5):485-96. doi: 10.1586/erv.10.43. Expert Rev Vaccines. 2010. PMID: 20450323 Review.
-
A new typhoid vaccine composed of the Vi capsular polysaccharide.Arch Intern Med. 1995 Nov 27;155(21):2293-9. Arch Intern Med. 1995. PMID: 7487253 Review.
Cited by
-
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S74-S82. doi: 10.1093/cid/ciy1107. Clin Infect Dis. 2019. PMID: 30845333 Free PMC article.
-
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S67-S73. doi: 10.1093/cid/ciy1106. Clin Infect Dis. 2019. PMID: 30845329 Free PMC article.
-
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.Front Immunol. 2023 Mar 23;14:1139329. doi: 10.3389/fimmu.2023.1139329. eCollection 2023. Front Immunol. 2023. PMID: 37033932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
